A first report by Murray and Nathan in 1999 demonstrated that both NADPH oxidase and NOS2 were involved in the early control of L. donovani replication in the liver, whereas NOS2 alone was sufficient to resolve late infection [13]. The gene discussed is FMO5; the disease is infection.